| EPA040 | Investigating mechanisms of antigen-independent CD8+ T cell enforcement of HIV latency | E-poster | Immune mechanisms of natural or post-treatment control |
| OAA0205 | Exceptional post-treatment control associated with strong NK and Ï?É? cytotoxic T cells | Oral abstract session with live Q&A | Immune mechanisms of natural or post-treatment control |
| EPA084 | Effects of COVID-19 on the cytokine background in chronic controlled HIV infection | E-poster | Immune responses to SARS-Cov2 |
| EPA085 | Vitamin D supplementation enhances cytotoxic response in patients with severe COVID-19 | E-poster | Immune responses to SARS-Cov2 |
| PEMOA30 | Persistent AP-1-induced immune activation during early SARS-CoV-2 infection revealed by simultaneous single-cell epigenetic and gene expression profiling | Poster exhibition | Immune responses to SARS-Cov2 |
| PEMOA31 | HIV skews the B cell response to SARS-CoV-2 toward extrafollicular maturation | Poster exhibition | Immune responses to SARS-Cov2 |
| PEMOA32 | The impact of delta and omicron variants in the T-cell response to mRNA vaccination in people living with HIV | Poster exhibition | Immune responses to SARS-Cov2 |
| PEMOA34 | Seroprevalence of cross-reactive anti-SARS-CoV-2 antibodies in pre-COVID-19 samples collected from Cameroonian women during pregnancy and at delivery | Poster exhibition | Immune responses to SARS-Cov2 |
| PESUA23 | Longer intervals between SARS-CoV-2 infection and SpikeVax doses improve the neutralization of different variants of concern | Poster exhibition | Immune responses to SARS-Cov2 |
| PESUA25 | Unvaccinated individuals admitted to the ICU due to fatal COVID-19 showed progressive decay of unresponsive cytotoxic cells | Poster exhibition | Immune responses to SARS-Cov2 |